Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionMcrae Capital Management Inc
Latest Disclosed Ownership1,186 shares
Latest Disclosed Value $ 417,294
Mcrae Capital Management Inc ownership in AMGN / Amgen Inc.

On May 14, 2026 - Mcrae Capital Management Inc filed a 13F-HR form disclosing ownership of 1,186 shares of Amgen Inc. (CH:AMGN) valued at $417,294 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,186 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN COM 031162100 1,186 0 0.00 417 7.47 0.0866
2026-02-10 2025-12-31 13F AMGEN COM 031162100 1,186 0 0.00 388 16.17 0.0792
2025-11-07 2025-09-30 13F AMGEN COM 031162100 1,186 0 0.00 335 0.91 0.0664
2025-08-06 2025-06-30 13F AMGEN COM 031162100 1,186 0 0.00 331 -10.30 0.0678
2025-05-13 2025-03-31 13F AMGEN COM 031162100 1,186 -309 -20.67 369 -5.14 0.0779
2025-01-30 2024-12-31 13F AMGEN COM 031162100 1,495 -500 -25.06 390 -39.41 0.0764
2024-10-24 2024-09-30 13F AMGEN COM 031162100 1,995 -391 -16.39 643 -13.83 0.1255
2024-07-24 2024-06-30 13F AMGEN COM 031162100 2,386 0 0.00 746 9.88 0.1700
2024-04-18 2024-03-31 13F AMGEN COM 031162100 2,386 -160 -6.28 678 -7.50 0.1486
2024-01-22 2023-12-31 13F AMGEN COM 031162100 2,546 -30 -1.16 733 5.92 0.1834
2023-10-17 2023-09-30 13F AMGEN COM 031162100 2,576 245 10.51 692 33.85 0.2050
2023-07-21 2023-06-30 13F AMGEN COM 031162100 2,331 0 0.00 518 -8.17 0.1471
2023-04-19 2023-03-31 13F AMGEN COM 031162100 2,331 0 0.00 564 -8.01 0.1622
2023-01-20 2022-12-31 13F AMGEN COM 031162100 2,331 0 0.00 612 16.57 0.1791
2022-10-20 2022-09-30 13F AMGEN COM 031162100 2,331 -9 -0.38 525 -7.73 0.1596
2022-07-20 2022-06-30 13F AMGEN COM 031162100 2,340 95 4.23 569 4.79 0.1544
2022-04-21 2022-03-31 13F AMGEN COM 031162100 2,245 0 0.00 543 7.52 0.1225
2022-01-26 2021-12-31 13F AMGEN COM 031162100 2,245 0 0.00 505 5.87 0.1053
2021-10-26 2021-09-30 13F AMGEN COM 031162100 2,245 0 0.00 477 -12.80 0.1050
2021-07-28 2021-06-30 13F AMGEN COM 031162100 2,245 9 0.40 547 -1.62 0.1251
2021-05-11 2021-03-31 13F AMGEN COM 031162100 2,236 0 0.00 556 8.17 0.1377
2021-01-27 2020-12-31 13F AMGEN COM 031162100 2,236 0 0.00 514 -9.51 0.1474
2020-11-09 2020-09-30 13F AMGEN COM 031162100 2,236 0 0.00 568 7.78 0.1904
2020-07-23 2020-06-30 13F AMGEN COM 031162100 2,236 0 0.00 527 16.34 0.1974
2020-04-16 2020-03-31 13F AMGEN COM 031162100 2,236 0 0.00 453 -15.96 0.2208
2020-01-17 2019-12-31 13F AMGEN COM 031162100 2,236 750 50.47 539 87.15 0.1985
2019-10-21 2019-09-30 13F AMGEN COM 031162100 1,486 0 0.00 288 5.11 0.1122
2019-07-29 2019-06-30 13F AMGEN COM 031162100 1,486 248 20.03 274 16.60 0.1096
2019-04-16 2019-03-31 13F AMGEN COM 031162100 1,238 -25 -1.98 235 -4.47 0.0979
2019-01-28 2018-12-31 13F AMGEN COM 031162100 1,263 -100 -7.34 246 -13.07 0.1265
2018-10-15 2018-09-30 13F AMGEN COM 031162100 1,363 -1,500 -52.39 283 -46.40 0.1200
2018-07-16 2018-06-30 13F AMGEN COM 031162100 2,863 1,525 113.98 528 131.58 0.2210
2018-05-09 2018-03-31 13F AMGEN COM 031162100 1,338 -25 -1.83 228 -3.80 0.1030
2018-02-13 2017-12-31 13F AMGEN COM 031162100 1,363 1,363 237 0.0999
2015-10-22 2015-09-30 13F AMGEN COM 031162100 0 -2,500 -100.00 0 -100.00
2015-07-28 2015-06-30 13F AMGEN COM 031162100 2,500 0 0.00 384 -4.00 0.1789
2015-04-30 2015-03-31 13F AMGEN COM 031162100 2,500 2,500 400 0.1844
2015-01-29 2014-12-31 13F AMGEN COM 031162100 0 -2,500 -100.00 0 -100.00
2014-11-03 2014-09-30 13F AMGEN COM 031162100 2,500 0 0.00 351 18.58 0.1705
2014-08-01 2014-06-30 13F AMGEN COM 031162100 2,500 0 0.00 296 -3.90 0.1426
2014-04-28 2014-03-31 13F AMGEN COM 031162100 2,500 0 0.00 308 8.07 0.1556
2014-01-30 2013-12-31 13F AMGEN COM 031162100 2,500 -120 -4.58 285 -2.73 0.1463
2013-10-22 2013-09-30 13F AMGEN COM 031162100 2,620 -700 -21.08 293 -10.67 0.1621
2013-07-30 2013-06-30 13F AMGEN COM 031162100 3,320 3,320 328 0.1909
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.